ACADIA Pharmaceuticals
ACAD
#3765
Rank
ยฃ2.62 B
Marketcap
ยฃ15.30
Share price
-1.01%
Change (1 day)
-6.77%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): ยฃ0.10 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are ยฃ1.07 Billion. a decrease over its 2024 earnings that were of ยฃ0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 ยฃ0.10 B-46.18%
2024 ยฃ0.19 B-605.67%
2023 -ยฃ38.14 Million-76.09%
2022 -ยฃ0.16 Billion27.41%
2021 -ยฃ0.13 Billion-40.38%
2020 -ยฃ0.21 Billion19.88%
2019 -ยฃ0.18 Billion-3.92%
2018 -ยฃ0.19 Billion-15.04%
2017 -ยฃ0.22 Billion6.33%
2016 -ยฃ0.21 Billion64.55%
2015 -ยฃ0.13 Billion77.47%
2014 -ยฃ69.1 Million143.69%
2013 -ยฃ28.36 Million81.93%
2012 -ยฃ15.59 Million-8.73%
2011 -ยฃ17.08 Million-251.39%
2010 ยฃ11.27 M-133.2%
2009 -ยฃ33.98 Million-30.82%
2008 -ยฃ49.11 Million6.43%
2007 -ยฃ46.15 Million25.89%
2006 -ยฃ36.66 Million36.99%
2005 -ยฃ26.76 Million37.22%
2004 -ยฃ19.5 Million19.96%
2003 -ยฃ16.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.41 B 18,602.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ7.91 B 7,524.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.25 B 22,307.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.17 B 6,809.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-ยฃ90.48 Million-187.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-ยฃ28.87 Million-127.81%๐Ÿ‡บ๐Ÿ‡ธ USA